Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in mammalian cells
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1985-11-12 to 1986-04-21
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1986
Report date:
1986

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
Deviations:
no
GLP compliance:
not specified
Type of assay:
mammalian cell gene mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Amines, rosin, compds. with 9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride and disodium hydrogen bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]chromate(3-)
EC Number:
308-114-5
EC Name:
Amines, rosin, compds. with 9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride and disodium hydrogen bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]chromate(3-)
Cas Number:
97862-65-2
Molecular formula:
C40H28CrN8O10S2.C28H31N2O3.C20H32N
IUPAC Name:
Amines, rosin, compds. with 9-(2-carboxyphenyl)-3,6-bis(diethylamino)xanthylium chloride and disodium hydrogen bis[4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-3-hydroxy-1-naphthalenesulfonato(3-)]chromate(3-)
Test material form:
solid: particulate/powder
Details on test material:
- Code No.: TK10363
- Batch No.: 42.29
- Physical state: Powder
Specific details on test material used for the study:
- Purity: Commercial grade

Method

Species / strain
Species / strain / cell type:
Chinese hamster lung fibroblasts (V79)
Details on mammalian cell type (if applicable):
- Type and identity of media: Hams's F10 tissue culture medium plus 3 % FCS
- Properly maintained: yes
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
S9 mix (aroclor1254 induced)
Test concentrations with justification for top dose:
Preliminary cytotoxixity test:
31 ng/mL to 2000 mg/mL

Main mutagenicity test
without metabolic activation: 0.5, 1, 2, 4, 8, 12, 16 and 20 µg/mL
with metabolic activation: 12.5, 25, 50, 100, 200, 300, 400 and 500 µg/mL
Vehicle / solvent:
The test item was dissolved in DMSO
Controls
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Remarks:
without metabolic activation: ethylmethanesulphonate; with metabolic activation: N-dimethylnitrosamine
Positive control substance:
N-dimethylnitrosamine
ethylmethanesulphonate
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium

DURATION
- Exposure duration: 5 h (with and without S9 mix)
- Expression time (cells in growth medium): 6 days
- Selection time (if incubation with a selection agent): 7 days



SELECTION AGENT: 6-thioguanine (6 TG) and 8-azaguanine (8 TG)
STAIN: Giemsa

NUMBER OF REPLICATIONS: 2
NUMBER OF EXPERIMENTS: 1

DETERMINATION OF CYTOTOXICITY
- Method: survivng colonies determined with the aid of an electric colony counter
Evaluation criteria:
A test substance is considered mutagenic in this test system, if the analysis of the data demonstrates either:
- a dose-dependent increase in the mutant frequency and
an increase in the highest mutant frequency with respect to the negative control by a factor of at least 2.5;
or
- an increase in any mutant frequency by a factor of 3.0 or more with respect to the negative control at any concentration tested and an absolute difference of at least 20 clones per 10 cells plated between the negative control and substance treated dishes.
Statistics:
All mutant frequencies are normalized to a virtual cloning efficiency of 100% at the end of the expression period. If the cloning efficiency is lower than 15%, the corresponding mutant frequency is usually not calculated, owing to the high statistical insignificance of the result.

Results and discussion

Test results
Key result
Species / strain:
Chinese hamster lung fibroblasts (V79)
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
90 % reduction in viability was observed between 125 - 250 µg/mL (with metabolic activation) and between 7.813 and 15.625(without metabolic activation).
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
RANGE-FINDING/SCREENING STUDIES: In the preliminary toxicity tests, a 90% reduction in the viability of the cells treated with the test item was obtained between the concentrations of 125 and 250 µg/mL in the experiment with microsomal activation and between the concentrations of 7.813 and 15.625 µg/mL in the experiment without microsomal activation.

COMPARISON WITH HISTORICAL CONTROL DATA: The mutant frequencies of the negative and positive controls were in the range of the historical control.

Any other information on results incl. tables

Table: Mutation frequencies without metabolic activation

Treatment conc. (µg/mL)

Mutant frequency (x10-6)

Selection Agent 8-AG

Selection Agent 6-TG

0.5

< 4.0

6.0

1.0

4.8

4.8

2.0

< 4.0

6.6

4.0

< 4.0

< 4.0

8.0

5.2

13.9

12.0

--

--

16.0

--

--

20.0

--

--

Solvent control

< 4.0

< 4.0

300 nL/mL EMS

3157.3

3712.0

 

Table: Mutation frequencies with metabolic activation

Treatment conc. (µg/mL)

Mutant frequency (x10-6)

Selection Agent 8-AG

Selection Agent 6-TG

13

< 4.0

5.1

25

< 4.0

< 4.0

50

< 4.0

4.7

100

15.7

15.7

200

< 4

<4

300

--

--

400

--

--

500

--

--

Solvent control

< 4.0

< 7.1

1 µL/mL DMN

800.0

683.0

 

Applicant's summary and conclusion

Executive summary:

The test material did not induce gene mutations in a mammalian cell line.